This is a working overview of Melanotan II, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-11-27 and is reviewed periodically as new material appears.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Handling guidance for melanotan II follows general practice for small synthetic peptides rather than a product-specific monograph. Lyophilized powder is typically kept at minus twenty degrees Celsius or colder, protected from light and moisture, because warmth and humidity accelerate degradation. Once reconstituted, solutions are usually refrigerated and used within a short window, as hydrolysis and microbial growth both become concerns. Repeated freeze-thaw cycles are generally avoided. These conventions come from laboratory peptide chemistry and not from formal stability studies on this specific compound.
Analytical confirmation of identity relies on mass spectrometry, most often coupled to liquid chromatography. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and provides a purity estimate based on peak area. Electrospray ionization mass spectrometry then confirms the expected molecular mass, while tandem mass spectrometry can map the fragment sequence. For research-grade material, these two techniques together form the standard minimum. Purity figures reported by vendors are frequently not traceable to an independent laboratory.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Belongs to the melanocortin agonist family |
| Key substitutions | Nle4 and D-Phe7 | Improve resistance to enzymatic degradation |
| Molecular formula | C50H69N15O9 | Approximately 1024 g/mol |
| Regulatory status | Not approved as a medicine | Distributed as a research chemical |
| Common synonyms | Melanotan II, MT-II, MT-2 | Spelling varies across sources |
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.
Melanotan-2 has not received marketing authorisation from major regulatory agencies for any therapeutic indication. Several jurisdictions classify it as a prescription-only medicine or a controlled substance when supplied for human use. Because approved products do not exist, material sold online usually sits outside pharmaceutical supply chains and formal quality oversight. Regulators have issued public notices describing the compound as unapproved. Enforcement varies, and the legal position differs between countries, which complicates any single general statement about its status.
Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.
=== Contraindications === The use of lysine vasopressin is contraindicated in the presence of hypersensitivity to beef or pork proteins, increased BUN and chronic kidney failure. It is recommended that it be cautiously used in instances of perioperative polyuria, sensitivity to the drug, asthma, seizures, heart failure, a comatose state, migraine headaches, and cardiovascular disease.
Juan Carlos Fuentes, from Venezuela Luis Ramón Amundarain, from Venezuela Eduard Hildalgo, from Venezuela Dushak Milovcic, from Venezuela Robert Sánchez, from Venezuela Jesús Carreño, from Venezuela Eduardo Jaime, from Venezuela Luis Alí Martínez, from Venezuela Alejandro Andrés Carranza Medina, from Colombia Ronald Arregocés, from Colombia Adrián Lino, from Colombia Pedro Ramón Holguín Holguín, from Ecuador Carlos Manuel Rodríguez Solórzano, from Ecuador Chad Joseph, from Trinidad and Tobago Rishi Samaroo, from Trinidad and Tobago Ricky Joseph, from Saint Lucia
Thermal ionization, also known as surface ionization or contact ionization, is a physical process whereby the atoms are desorbed from a hot surface, and in the process are ionized. Thermal ionization is used to make simple ion sources, for mass spectrometry and for generating ion beams. Thermal ionization has seen extensive use in determining atomic weights, in addition to being used in many geological/nuclear applications.
Sources: en.wikipedia.org
=== Biosynthetic Spider Silk in E. coli === Ancient Greeks and Romans used spider silk to stop bleeding and aid wound healing and in more modern history, indigenous people in the Solomon Islands as well as Aboriginals created fishing setups from spider silk utilizing it as fishing line. One of the most common methods of producing spider silk biosynthetically utilizes bacteria, such as Escherichia coli (E. coli). The E. coli cell DNA is engineered to express spider silk genes, producing spidroin proteins within the cells. These proteins are then extracted, purified and spun into fibers. While E. coli can produce relatively high yields (e.g., up to 2,700 mg/liter for some MaSp1 variants), process efficiency is very low and many challenges remain in ensuring proper protein folding and solubility for optimal fiber properties, especially for larger spidroin constructs which often cause cell toxicity and death. The table below provides the mechanical properties of the spider silk from a few species to establish a general overview of the mechanical properties. There are then listed a few notable biosynthetic spider silk examples produced in E. coli from recent work.
== History == The programme originated in response to protests by dairy farmers in 1984 over surplus unsold milk. To address the issue, the Thai Cabinet established the National Milk Drinking Campaign Board in 1985 and launched a pilot project in Bangkok and Chiang Mai that offered milk at subsidized rates to parents of schoolchildren. Following the success of the pilot, the government introduced a nationwide programme in 1992 to distribute free milk to public schools. The programme significantly contributed to the growth of Thailand’s dairy sector. Annual milk production rose from approximately 290 million litres in the early 1990s to more than 1.1 billion litres by 2003, while per capita milk consumption increased from about 2 litres in 1984 to over 23 litres in 2002. Between 2009 and 2018, competition for milk supply quotas led to various administrative and quality concerns, including reports of spoiled milk and inefficient distribution. In 2019, reforms were introduced to improve transparency and re-establish clear quota zones for suppliers.
Hemp Microgreens Powder works well as a seasoning on salads, in smoothies or just mixed in pure water. Hemp salt: Hemp juice is mixed and dried with good quality table salt. It can be used for cooked as well as uncooked dishes. Henceforth, cannabinoids are consumed in their natural cannabinoid-acid form as well as in their activated form. Hemp salt helps reduce salt intake due to its natural effect of intensifying flavors. Hemp sugar or hemp syrup: Hemp juice can lower sugar intake when consumed in combination with fruit juices, sweet dishes, or sugar because it intensifies sweet flavors significantly. Hemp juice and its umami flavor enhance the savory taste of any dish and is suitable for use in mixing, cooking, baking, ready meals, beverages, seasoning, pastries, jams, and soups (Siemieniotka).
Sources: en.wikipedia.org
It is a synthetic cyclic peptide designed as an analog of alpha-melanocyte-stimulating hormone. It acts on melanocortin receptors and is best known from research into pigmentation. It is not an approved pharmaceutical product.
No regulatory agency has approved it for any indication. It is encountered as a research chemical sold outside pharmaceutical supply chains. Products marketed this way are not subject to the manufacturing and labeling requirements that apply to approved drugs.
Reports describe increased skin pigmentation as well as side effects such as nausea, flushing, and changes to existing moles. Much of the evidence comes from small studies and case reports rather than large trials. The long-term safety profile is therefore uncertain.
The lyophilized powder is generally held at minus twenty degrees Celsius or below, away from light and moisture. Reconstituted solutions are typically refrigerated and used quickly. These practices derive from general peptide handling rather than a formal stability study.